Apollomics Inc

Biotech Stocks Healthcare Stocks

$14.36

+0.76 (+5.59%)

As of May 16, 2:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -13.7% upside

Low Target $7.78

Average Target $12.39

High Target $16.73

Current Price $14.36

Current
$14.36

Target
$12.39

$7.78 $12.39 avg $16.73

Scenario Analysis

Bear Case

$7.78

-45.8%

Low target

Base Case

$12.39

-13.7%

Avg target

Bull Case

$16.73

+16.5%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$42.12

-65.9% from high

52-Week Low

$3.66

+292.5% from low

Target vs 52W High

$12.39

-70.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%